Current Management of Pediatric Vitiligo

@article{Driessche2015CurrentMO,
  title={Current Management of Pediatric Vitiligo},
  author={Freya Van Driessche and Nanette B. Silverberg},
  journal={Pediatric Drugs},
  year={2015},
  volume={17},
  pages={303-313},
  url={https://api.semanticscholar.org/CorpusID:20038695}
}
Medical interventions are largely the usage of topical therapies including corticosteroids and calcineurin inhibitors, some vitamin therapy (oral and topical vitamin D), and judicious introduction of phototherapy sources based on age and severity, which may enhance overall health.

Clinical efficacy analysis of 110 cases of childhood vitiligo with non-surgical combined therapy

Treatment lasting longer than 1 year is recommended in children with vitiligo and the best repigmentation effect can be achieved by combination therapy in the rapid progression stage.

A child with vitiligo

There are many therapeutic options for vitiligo, none of which is fully effective, hence appropriate patients education concerning various medical and cosmetic therapies, as well as the psychological aspects of the disease is extremely important.

Therapeutic interventions to lessen the psychosocial effect of vitiligo in children: A review

There is an ongoing need for studies to better understand the modalities described in this article, as well as others, such as skin dyes, bleaching creams, medical tattooing; week‐long camps that cater to children with chronic skin disease; and biofeedback, that might have a role in preventing the psychosocial sequelae of childhood vitiligo.

A Single-Center Retrospective Study of Pediatric Vitiligo in a Tertiary Hospital

A long-term follow-up of children with vitiligo is needed to identify treatment side effects and diseases associated and concur with the scarce literature.

A prospective study of vitiligo cases in Government Dharmapuri Medical College Hospital

100 cases of vitiligo patients attending Dermatology outpatient Department at Govt Dharmapuri Medical college hospital during the period of January 2017 to June 2017 were included in the study.

Recent Advances in Pathogenesis and Medical Management of Vitiligo

The unravelling of interferon (IFN)-γ/CXCL10 axis in the causation of melanocyte directed attack and the observation of clinical usefulness of tofacitinib, which blocks the same pathway, give new hope in the direction of targeted therapy in vitiligo.

Treatment of vitiligo in children

This review presents current and effective methods of vitiligo treatment in pediatric patients and their implications for quality of life and self-esteem.

Widespread Depigmented and Hypopigmented Patches

Female patients with longer duration of disease and patients with extensive involvement are more likely to develop autoimmune thyroid disease and anti-nuclear antibody positivity is seen more frequently in female patients and in early-onset disease.

Guidelines for the management of vitiligo

These comprehensive guidelines for the diagnosis and management of vitiligo in coloured skin aims to give high quality clinical advice, based on the best available evidence and expert consensus.

Vitiligo Therapy in Children: A Case for Considering Excimer Laser Treatment

Overall, the distribution of vitiligo cases seems to be equal between adult men and women, but in the pediatric population, vitILigo presents significantly more often in girls than in boys.

Vitiligo Treatment in Childhood: A State of the Art Review

It is found that narrow‐band ultraviolet B (UVB) has better overall repigmentation rates and safety profile than either topical or oral psoralens and ultraviolet A (PUVA) and the option of no treatment with or without corrective camouflage, is an innocuous alternative to any of these treatment modalities.

Narrow‐band UVB for the treatment of generalized vitiligo in children

Narrow‐band UVB is an effective and well‐tolerated treatment option for childhood vitiligo.

Quality of Life Impairment in Children and Adolescents with Vitiligo

An online parental questionnaire‐based study regarding children ages 0 to 17 years with vitiligo found that an affected BSA of more than 25% was associated with self‐consciousness, difficulty with friendships and schoolwork, and teasing and bullying.

Thyroid abnormalities in pediatric patients with vitiligo in New York City.

The results are comparable to the European literature and highlight the need for thyroid screening in children with vitiligo vulgaris of a generalized nonsegmental type.

Celiac disease in childhood: evaluation of 140 patients.

In order to avoid overlooking CD in patients with extra intestinal symptoms and signs, physicians, especially pediatricians, should be informed about new atypical manifestations of CD.
...